CCRT for Esophageal Cancer.

NCT02607982 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer
Concurrent Chemoradiotherapy
Oxaliplatin
Paclitaxel

Interventions

DRUG: Paclitaxel
DRUG: Oxaliplatin
RADIATION: Radiotherapy

Sponsor

Hangzhou Cancer Hospital